Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) [Phase 3]
A Phase 3 trial assessed the efficacy and safety of sorafenib in advanced renal cell carcinoma, reporting results from this setting. The upd…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Expanded access study of RAD001 (everolimus) in patients with metastatic renal cell carcinoma. The study is no longer available.
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating Panzem NCD, alone and in combination with Sunitinib Malate, …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Cancer in Patients With Gabapentin (GPRD)
This clinical trial update reports cancer outcomes in patients treated with gabapentin, with results posted in 2011. It lists several cancer…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow [Phase 2]
Phase 2 trial evaluating sunitinib malate in patients with Von Hippel-Lindau disease and VHL-associated lesions; the study was terminated an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma [Phase 2]
Clinical Trial Update reports a Phase 2 study of Sunitinib in advanced non-clear cell renal cell carcinoma, specifically metastatic renal ce…
-
FDA approval · 2011-06-16FDA Approved: TORISEL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approves a supplemental application for Torisel (temsirolimus) from Wyeth Pharmaceuticals (Pfizer), related to an update to the product'…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer [Phase 2]
A Phase 2 trial evaluating daily 37.5 mg sunitinib malate in patients with advanced renal cell carcinoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Cancer [Phase 2]
Phase 2 clinical trial update of a biological therapy for metastatic cancer has completed; the study includes kidney cancer, melanoma, and o…
-
CLINICAL_TRIALS research · 2011-05-10Clinical Trial Update: Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus
A completed clinical trial investigating prognostic factors in renal cell carcinoma with venous tumor thrombus.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating interferon alfa-1b in kidney cancer, including metastatic disease, has completed.
-
CLINICAL_TRIALS research · 2011-03-08Clinical Trial Update: DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a dendritic cell vaccine in combination with cytokine-induced killer cells for renal cell carcinoma.
-
CLINICAL_TRIALS research · 2011-01-26Clinical Trial Update: Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) [Phase 2]
An update on the Phase 2 exploratory trial of ZD6126 in newly diagnosed metastatic renal cell carcinoma indicates the study is suspended.
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating a pentostatin-alemtuzumab preparative regimen for allogeneic peripheral blood stem cell transplantation; the study …
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
This clinical trial update evaluated whether gabapentin affects the risk of pancreatic and renal cancers; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing sorafenib with interferon alpha-2a in patients with unresectable or metastatic renal cell carcinoma; results have be…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC) [Phase 1, Phase 2]
Phase 1/2 trial evaluating stereotactic body radiotherapy in combination with sorafenib for metastatic, recurrent, or unresectable renal cel…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma [Phase 1]
This entry notes completion of a Phase 1 trial evaluating a novel peptide vaccination for advanced renal cell carcinoma.
-
CLINICAL_TRIALS research · 2010-11-15Clinical Trial Update: Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is investigating cytokine-induced killer (CIK) cells stimulated by dendritic cell immunotherapy in patients…
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma
Clinical trial update reporting effects of sunitinib (Sutent) on tumor vascularization and necrosis in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: SUTENT® In The First Line Treatment Of Renal Cell Carcinoma
A clinical trial evaluating SUTENT (sunitinib) as first-line treatment for renal cell carcinoma has completed, with results posted in 2010.
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)
This document provides a clinical trial update/protocol assessing hormones involved in serum phosphate balance in patients with metastatic r…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC) [Phase 3]
Phase III trial evaluating sorafenib in renal cell carcinoma has been completed, with results posted in October 2010.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer. [Phase 2]
A Phase 2 trial assessed sorafenib alone and in combination with low-dose interferon in patients with advanced renal cell carcinoma that pro…
-
CLINICAL_TRIALS trial_result · 2010-09-30Clinical Trial Update: Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
A completed clinical trial update describing patient characteristics in advanced renal cell carcinoma and the use of Nexavar (sorafenib) in …